Cite
Comparative study between obstetric antiphospholipid syndrome and obstetric morbidity related with antiphospholipid antibodies.
MLA
Alijotas-Reig, Jaume, et al. “Comparative Study between Obstetric Antiphospholipid Syndrome and Obstetric Morbidity Related with Antiphospholipid Antibodies.” Medicina Clinica, vol. 151, no. 6, Sept. 2018, pp. 215–22. EBSCOhost, https://doi.org/10.1016/j.medcli.2017.11.017.
APA
Alijotas-Reig, J., Esteve-Valverde, E., Ferrer-Oliveras, R., LLurba, E., Ruffatti, A., Tincani, A., Lefkou, E., Bertero, M. T., Espinosa, G., de Carolis, S., Rovere-Querini, P., Lundelin, K., Picardo, E., & Mekinian, A. (2018). Comparative study between obstetric antiphospholipid syndrome and obstetric morbidity related with antiphospholipid antibodies. Medicina Clinica, 151(6), 215–222. https://doi.org/10.1016/j.medcli.2017.11.017
Chicago
Alijotas-Reig, Jaume, Enrique Esteve-Valverde, Raquel Ferrer-Oliveras, Elisa LLurba, Amelia Ruffatti, Angela Tincani, Elmina Lefkou, et al. 2018. “Comparative Study between Obstetric Antiphospholipid Syndrome and Obstetric Morbidity Related with Antiphospholipid Antibodies.” Medicina Clinica 151 (6): 215–22. doi:10.1016/j.medcli.2017.11.017.